Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|August 12, 2008
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an updateEdoardo Spina, Vincenza Santoro, Concetta D'Arrigo
Fundamental & Clinical Pharmacology|January 6, 2004
Metabolic drug interactions with new psychotropic agentsEdoardo Spina, Maria Gabriella Scordo, Concetta D'Arrigo
Therapeutic Drug Monitoring|June 17, 2006
Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detectionConcetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 16, 2012
Interactions between antiepileptics and second-generation antipsychoticsJose de Leon, Vincenza Santoro, Concetta D'Arrigo, et al.
Pharmacological Research|June 5, 2004
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian populationMaria Gabriella Scordo, Achille P Caputi, Concetta D'Arrigo, et al.
Journal of Child and Adolescent Psychopharmacology|May 15, 2004
Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implicationsAntonella Gagliano, Eva Germanò, Giuseppina Pustorino, et al.
Therapeutic Drug Monitoring|July 17, 2004
Plasma risperidone concentrations during combined treatment with sertralineEdoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, et al.
Pharmacological Research|October 18, 2005
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophreniaConcetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, et al.
Clinical Neuropharmacology|April 7, 2007
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disordersGaetana Migliardi, Concetta D'Arrigo, Vincenza Santoro, et al.
Pageof 2